Natasha Sheybani

Last updated
Natasha Sheybani
Alma materVirginia Commonwealth University (BS)

University of Virginia (Ph.D)

Stanford University (Post-Doc)
Known forFocused Ultrasound Research
Scientific career
FieldsBiomedical Engineering

Oncology

Radiology

Natasha Sheybani is an American biomedical engineer who is an assistant professor of Biomedical engineering at the University of Virginia. [1] [2] In 2022, she was appointed as the inaugural research director of the Focused Ultrasound Cancer Immunotherapy Center at the University of Virginia, the first of its kind in the world. [3] [4]

Contents

She was named one of Forbes 30 Under 30 in Science in 2022 and a STAT Wunderkind in 2020. [5] [6] [7]

Education

Sheybani earned her Bachelor of Science in Biomedical Engineering from Virginia Commonwealth University in 2015. [1] She went on to earn a Ph.D in Biomedical Engineering at the University of Virginia in 2020. [8] [2]

Publications

References

  1. 1 2 Sheybani, Natasha Diba; Charlottesville, Ph D. Biomedical Engineering MR5 1123 MR5 1225 415 Lane Road | Box 800759 (2022-02-14). "Natasha D. Sheybani". University of Virginia School of Engineering and Applied Science. Retrieved 2022-11-15.{{cite web}}: CS1 maint: numeric names: authors list (link)
  2. 1 2 "Former UVA student honored as upcoming scientific superstar". www.cbs19news.com. Retrieved 2022-11-15.
  3. Barney, Joshua (2022-05-11). "World's 1st Focused Ultrasound Cancer Immunotherapy Center Launched". UVA Health Newsroom. Retrieved 2025-04-19.
  4. "Leadership & Faculty". Focused Ultrasound Cancer Immunotherapy Center. Retrieved 2025-04-19.
  5. Paschall, C. J. (17 November 2020). "Researcher named 2020 "Wunderkind" for research done at UVA". www.nbc29.com. Retrieved 2022-11-15.
  6. "Engineering professor's work with targeted ultrasound waves honored in Forbes "30 Under 30"". The Cavalier Daily - University of Virginia's Student Newspaper. Retrieved 2022-11-15.
  7. "Meet the Trio of UVA Alumni on the 2022 Forbes '30 Under 30' Lists". UVA Today. 2021-12-23. Retrieved 2022-11-15.
  8. "Natasha Sheybani". STAT. Retrieved 2022-05-02.
  9. Curley, Colleen T.; Sheybani, Natasha D.; Bullock, Timothy N.; Price, Richard J. (2017). "Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities". Theranostics. 7 (15): 3608–3623. doi:10.7150/thno.21225. ISSN   1838-7640. PMC   5667336 . PMID   29109764.
  10. Sheybani, Natasha D.; Witter, Alexandra R.; Garrison, William J.; Miller, G. Wilson; Price, Richard J.; Bullock, Timothy N. J. (January 2022). "Profiling of the immune landscape in murine glioblastoma following blood brain/tumor barrier disruption with MR image-guided focused ultrasound". Journal of Neuro-Oncology. 156 (1): 109–122. doi:10.1007/s11060-021-03887-4. ISSN   1573-7373. PMC   8714701 . PMID   34734364.
  11. Clark, Ryan A.; Garman, Zoe G.; Price, Richard J.; Sheybani, Natasha D. (November 2021). "Functional intersections between extracellular vesicles and oncolytic therapies". Trends in Pharmacological Sciences. 42 (11): 883–896. doi:10.1016/j.tips.2021.09.001. ISSN   1873-3735. PMC   8526420 . PMID   34598797.
  12. Sheybani, Natasha D.; Breza, Victoria R.; Paul, Soumen; McCauley, Katelyenn S.; Berr, Stuart S.; Miller, G. Wilson; Neumann, Kiel D.; Price, Richard J. (2021-03-10). "ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls glioma". Journal of Controlled Release. 331: 19–29. doi:10.1016/j.jconrel.2021.01.023. ISSN   0168-3659. PMC   7946780 . PMID   33476735.
  13. Sheybani, Natasha D.; Batts, Alec J.; Mathew, Alexander S.; Thim, E. Andrew; Price, Richard J. (2020-06-12). "Focused Ultrasound Hyperthermia Augments Release of Glioma-derived Extracellular Vesicles with Differential Immunomodulatory Capacity". Theranostics. 10 (16): 7436–7447. doi:10.7150/thno.46534. ISSN   1838-7640. PMC   7330848 . PMID   32642004.